TransMedics Group (TMDX) Earnings Date, Estimates & Call Transcripts $78.58 +2.54 (+3.34%) (As of 11/25/2024 ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends TransMedics Group Latest Earnings SummaryUpcoming Q4 Earnings DateFeb. 24EstimatedActual EPS (Oct. 28) $0.12 Missed By -$0.17 Consensus EPS (Oct. 28) $0.29 TransMedics Group announced Q3 2024 earnings on October 28, 2024, reporting an EPS of $0.12, which missed analysts' consensus estimates of $0.29 by $0.17. Quarterly revenue rose 63.7% year-over-year to $108.76 million, below analyst estimates of $115 million. With a trailing EPS of $0.94 and a P/E Ratio of 83.60, TransMedics Group's earnings are expected to grow 56.00% next year, from $1.00 to $1.56 per share. Conference Call TranscriptConference Call AudioTMDX Upcoming EarningsTransMedics Group's next earnings date is estimated for Monday, February 24, 2025, based off prior year's reporting schedules. Get TransMedics Group Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TransMedics Group and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataTMDX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TMDX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilson, an extremely rare window in the markets is about to open. It's an often-misunderstood market setup we've only seen 13 times since 1920. The last time this happened, it minted a million brand-new millionaires – in a single year. But Tilson says this unique window in the markets could close much sooner than anyone realizes, leaving most investors in the dust, while making a select few incredibly rich.Get our No. 1 stock (with 500%-plus upside potential) for this rare market event now. TransMedics Group Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242-$0.19-$0.03-$0.11Q2 20242-$0.09$0.10$0.01Q3 20242$0.03$0.06$0.05Q4 20242$0.22$0.22$0.22FY 20248-$0.03$0.35$0.16Q1 20251$0.35$0.35$0.35Q2 20251$0.44$0.44$0.44Q3 20251$0.45$0.45$0.45Q4 20251$0.50$0.50$0.50FY 20254$1.74$1.74$1.74 TransMedics Group Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 2/24/2025(Estimated)------- 10/28/2024Q3 2024$0.29$0.12 -$0.17$0.12$115.00M$108.76M 7/31/2024Q2 2024$0.21$0.35+$0.14$0.35$98.84M$114.30M 4/30/2024Q1 2024-$0.05$0.35+$0.40$0.35$83.78M$96.90M 2/26/2024Q4 2023-$0.10$0.12+$0.22$0.12$68.49M$81.20M 11/6/2023Q3 2023-$0.18-$0.12+$0.06$0.54$48.05M$66.43M 8/3/2023Q2 2023-$0.15-$0.03+$0.12-$0.03$42.42M$42.46M 9 hidden AI stocks set to thrive in Trump’s new era (Ad)AI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be worth trillions of dollars (here’s how to tap into this new wealth)Get the Name of These AI Picks Now5/1/2023Q1 2023-$0.25-$0.08+$0.17-$0.08$36.05M$41.60M 2/22/2023Q4 2022-$0.28-$0.21+$0.07-$0.21$23.60M$31.38M TransMedics Group Earnings - Frequently Asked Questions When is TransMedics Group's earnings date? TransMedics Group has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 24th, 2025 based off last year's report dates. Learn more on TMDX's earnings history. What guidance has TransMedics Group issued on next quarter's earnings? TransMedics Group issued an update on its FY 2024 earnings guidance on Monday, October, 28th. The company issued revenue guidance of $425.0 million-$445.0 million, compared to the consensus revenue estimate of $444.4 million. Did TransMedics Group beat their earnings estimates last quarter? In the previous quarter, TransMedics Group (NASDAQ:TMDX) missed the analysts' consensus estimate of $0.29 by $0.17 with a reported earnings per share (EPS) of $0.12. Learn more on analysts' earnings estimate vs. TMDX's actual earnings. How can I listen to TransMedics Group's earnings conference call? The conference call for TransMedics Group's latest earnings report can be listened to online. Listen to Conference Call How can I read TransMedics Group's conference call transcript? The conference call transcript for TransMedics Group's latest earnings report can be read online. Read Transcript How much revenue does TransMedics Group generate each year? TransMedics Group (NASDAQ:TMDX) has a recorded annual revenue of $241.62 million. How much profit does TransMedics Group generate each year? TransMedics Group (NASDAQ:TMDX) has a recorded net income of -$25.03 million. TMDX has generated $0.94 earnings per share over the last four quarters. What is TransMedics Group's price-to-earnings ratio? TransMedics Group (NASDAQ:TMDX) has a trailing price-to-earnings ratio of 83.60 and a forward price-to-earnings ratio of 78.58. What is TransMedics Group's EPS forecast for next year? TransMedics Group's earnings are expected to grow from $1.00 per share to $1.56 per share in the next year, which is a 56.00% increase. ` More Earnings Resources from MarketBeat Related Companies PEN Earnings Results GKOS Earnings Results BLCO Earnings Results INSP Earnings Results PRCT Earnings Results NVST Earnings Results AXNX Earnings Results NARI Earnings Results LIVN Earnings Results ENOV Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings Report The Biggest Post-Election Market Shift Ever? (Ad)Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilson, an extremely rare window in the markets is about to open. It's an often-misunderstood market setup we've only seen 13 times since 1920. The last time this happened, it minted a million brand-new millionaires – in a single year. But Tilson says this unique window in the markets could close much sooner than anyone realizes, leaving most investors in the dust, while making a select few incredibly rich.Get our No. 1 stock (with 500%-plus upside potential) for this rare market event now. This page (NASDAQ:TMDX) was last updated on 11/26/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMUST-SEE: Everyone will be talking about this $2 trillion AI tech boom soonAmazon is making its biggest investment ever… $150 billion to be exact. And one company stands to benefit...Banyan Hill Publishing | Sponsored140% Yields From Stocks Like Tesla? Here's How (Black Friday Special)140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of ...Investors Alley | Sponsored9 hidden AI stocks set to thrive in Trump’s new eraAI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be wor...StockEarnings | SponsoredFormer Trump advisor issues urgent warningElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransMedics Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TransMedics Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
